Loading clinical trials...
Loading clinical trials...
Adult participants with BMI between 22 - 35 kg/m2 will be enrolled and randomized to receive either NG101 (20 mg twice daily \[BID\]) or placebo for 5 days beginning on Day 1. On Day 2, all participan...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neurogastrx, Inc.
NCT06631261 · Bronchiectasis Adult, Healthy Controls Group - Age and Sex-matched
NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more
NCT07545590 · Healthy
NCT07258836 · Neoplasms, Healthy
NCT00090662 · Healthy Volunteer
Celerion
Tempe, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions